{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:03:57Z","timestamp":1774026237236,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Adherence of kidney transplant recipients (KTRs) to prescribed regimens is vital for long-term graft function. This study aimed to identify adherence rates using objective and composite measures, risk factors for nonadherence, and the latter\u2019s impact on posttransplant outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>A retrospective single-center cohort study was conducted among KTR transplanted from January 1, 2003, to December 31, 2017. Overall nonadherence was defined as 1 or more of the following in the first-year posttransplant: (1) at least 1 missed clinic visit, (2)\u2005&gt;30% missed laboratory visits, and (3)\u2005&gt;40% coefficient of variation of calcineurin inhibitor levels. Logistic and Cox proportional hazards models were fitted to identify adherence risk factors and outcomes, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Among the included 1803 KTR, overall nonadherence was identified in 34.9%; 11.2% were nonadherent to clinic visits, 5.4% to laboratory tests, and 25.2% to medications. Recipient history of psychiatric disorders (odds artio [OR], 1.57; 95% confidence interval [CI], 1.22-2.02) or pretransplant nonadherence (OR, 1.82; 95% CI, 1.31\u20132.54), and private drug coverage (OR, 0.62; 95% CI, 0.48-0.80) were associated with posttransplant nonadherence. Any episode of nonadherence over the first year after transplant was associated with an increased risk of total graft failure (hazard ratio [HR], 1.52; 95% CI, 1.20-1.91), death with graft function (HR, 1.51; 95% CI, 1.11-2.05), and biopsy-proven acute rejection (HR, 2.35; 95% CI, 1.38-3.99).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Adherence among KTR is influenced by both psychosocial and socioeconomic determinants which impact posttransplant outcomes. Our results emphasize feasible methods to monitor adherence and identify high-risk KTR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001799","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:08Z","timestamp":1747094408000},"page":"e1799","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Assessing Risk Factors and Posttransplant Outcomes of Nonadherence Among Kidney Transplant Recipients"],"prefix":"10.1097","volume":"11","author":[{"given":"Kateryna","family":"Maksyutynska","sequence":"first","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict","family":"Batoy","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wei","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswa","family":"Shafei","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusegun","family":"Famure","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-9831","authenticated-orcid":false,"given":"S. Joseph","family":"Kim","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada."},{"name":"Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/ndt\/gfx365","article-title":"Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board.","volume":"33","author":"Abramowicz","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"100511","DOI":"10.1016\/j.trre.2019.100511","article-title":"Medication non-adherence after kidney transplantation: a critical appraisal and systematic review.","volume":"34","author":"Gokoel","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ackd.2016.07.001","article-title":"Current status of kidney transplant outcomes: dying to survive.","volume":"23","author":"Wang","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation.","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ejhpharm-2012-000258","article-title":"Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation.","volume":"20","author":"Johnston","year":"2013","journal-title":"Eur J Hosp Pharm"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.healun.2009.05.001","article-title":"Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.","volume":"28","author":"Uber","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/11317230-000000000-00000","article-title":"Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: Part I.","volume":"48","author":"Monchaud","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"e13353","DOI":"10.1111\/ctr.13353","article-title":"Report from the American Society of Transplantation Psychosocial Community of Practice Adherence Task Force: real-world options for promoting adherence in adult recipients.","volume":"32","author":"Myaskovsky","year":"2018","journal-title":"Clin Transplant"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ajt.15199","article-title":"Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values.","volume":"19","author":"Leino","year":"2019","journal-title":"Am J Transplant"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2016.10.017","article-title":"Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial.","volume":"69","author":"Reese","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"e2196","DOI":"10.1097\/MD.0000000000002196","article-title":"Transitional care and adherence of adolescents and young adults after kidney transplantation in Germany and Austria.","volume":"94","author":"Kreuzer","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/ctr.12821","article-title":"Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients.","volume":"30","author":"Patzer","year":"2016","journal-title":"Clin Transplant"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/ajt.13701","article-title":"A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation.","volume":"16","author":"Dabbs","year":"2016","journal-title":"Am J Transplant"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2215\/CJN.07241009","article-title":"Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.","volume":"5","author":"Prendergast","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.transproceed.2016.05.008","article-title":"A new quantitative approach to assessing noncompliance with medical recommendations in heart transplant recipients.","volume":"48","author":"S\u00e1nchez","year":"2016","journal-title":"Transplant Proc"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1331\/JAPhA.2011.09154","article-title":"Selection of a validated scale for measuring medication adherence.","volume":"51","author":"Lavsa","year":"2011","journal-title":"J Am Pharm Assoc (2003)"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.hcmf.2013.11.002","article-title":"Health information management for research and quality assurance: the comprehensive renal transplant research information system.","volume":"27","author":"Famure","year":"2014","journal-title":"Healthc Manage Forum"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000453554","article-title":"The impact of health care appointment non-adherence on graft outcomes in kidney transplantation.","volume":"45","author":"Taber","year":"2017","journal-title":"Am J Nephrol"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/fcp.12328","article-title":"Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year.","volume":"32","author":"Belaiche","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/TP.0000000000002052","article-title":"High intrapatient variability of tacrolimus exposure in the early period after liver transplantation is associated with poorer outcomes.","volume":"102","author":"Rayar","year":"2018","journal-title":"Transplantation"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jpsychores.2017.12.013","article-title":"Pre-transplant history of mental health concerns, non-adherence, and post-transplant outcomes in kidney transplant recipients.","volume":"105","author":"Gumabay","year":"2018","journal-title":"J Psychosom Res"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.TP.0000110408.83054.88","article-title":"Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review.","volume":"77","author":"Butler","year":"2004","journal-title":"Transplantation"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40620-015-0230-0","article-title":"Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.","volume":"29","author":"O\u2019Regan","year":"2016","journal-title":"J Nephrol"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1097\/TXD.0000000000000710","article-title":"High intrapatient variability of tacrolimus levels and outpatient clinic nonattendance are associated with inferior outcomes in renal transplant patients.","volume":"3","author":"Goodall","year":"2017","journal-title":"Transplant Direct"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10880-015-9427-6","article-title":"Quality improvement targeting adherence during the transition from a pediatric to adult liver transplant clinic.","volume":"22","author":"Fredericks","year":"2015","journal-title":"J Clin Psychol Med Settings"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"e12820","DOI":"10.1111\/petr.12820","article-title":"Transition to adult care for pediatric liver transplant recipients: the Western Australian experience.","volume":"21","author":"Mitchell","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ckj\/sfv054","article-title":"Management and prevention of post-transplant malignancies in kidney transplant recipients.","volume":"8","author":"Stallone","year":"2015","journal-title":"Clin Kidney J"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-0012.2009.01098.x","article-title":"Physical training effects in renal transplant recipients.","volume":"24","author":"Romano","year":"2010","journal-title":"Clin Transplant"},{"key":"R30-20250512","first-page":"e13899","article-title":"Adherence to laboratory testing in pediatric liver transplant recipients.","volume":"00","author":"Ryan","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/TP.0b013e3181a440ae","article-title":"Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening.","volume":"87","author":"Dobbels","year":"2009","journal-title":"Transplantation"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/152692481102100412","article-title":"Interventions used by health care professionals to enhance medication adherence in transplant patients: a survey of current clinical practice.","volume":"21","author":"Berben","year":"2011","journal-title":"Prog Transplant"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejcnurse.2010.10.004","article-title":"Which interventions are used by health care professionals to enhance medication adherence in cardiovascular patients? A survey of current clinical practice.","volume":"10","author":"Berben","year":"2011","journal-title":"Eur J Cardiovasc Nurs"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/ajt.12341","article-title":"Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial.","volume":"13","author":"Chisholm-Burns","year":"2013","journal-title":"Am J Transplant"},{"key":"R35-20250512","first-page":"589","article-title":"Effectiveness of motivational interviewing interventions on medication adherence in adults with chronic diseases: a systematic review and meta-analysis.","volume":"46","author":"Zomahoun","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ajt.15528","article-title":"Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: System CHANGETM results of the MAGIC randomized clinical trial.","volume":"20","author":"Russell","year":"2020","journal-title":"Am J Transplant"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"e12505","DOI":"10.2196\/12505","article-title":"Mobile apps for increasing treatment adherence: systematic review.","volume":"21","author":"P\u00e9rez-Jover","year":"2019","journal-title":"J Med Internet Res"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/ckj\/sfac017","article-title":"Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation.","volume":"15","author":"Gandolfini","year":"2022","journal-title":"Clin Kidney J"},{"key":"R39-20250512","first-page":"CD012854","article-title":"Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.","volume":"9","author":"Mellon","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"100900","DOI":"10.1016\/j.trre.2024.100900","article-title":"Non-adherence to immunosuppressive medications in kidney transplant recipients- a systematic scoping review.","volume":"39","author":"Corr","year":"2025","journal-title":"Transplant Rev (Orlando)"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ajt.15632","article-title":"Multicomponent interventions improve adherence-where do we go from here?","volume":"20","author":"Foster","year":"2020","journal-title":"Am J Transplant"},{"key":"R42-20250512","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/JHQ.0000000000000327","article-title":"Cost-effectiveness analysis: personal systems approach in improving medication adherence in adult kidney transplant patients.","volume":"44","author":"Whittington","year":"2022","journal-title":"J Healthc Qual"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables.","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:17Z","timestamp":1747094417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001799","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}